Roche vs AstraZeneca: Revenue Comparison
Roche (RHHBY) and AstraZeneca (AZN) are peers in GLP-1. Roche reported revenue of $34.3B as of Q4 2025, compared with $15.3B for AstraZeneca. Roche leads on revenue.
Roche's gross margin is 71.7% versus 82.5% for AstraZeneca. Roche's net margin is 17.9% versus 20.1% for AstraZeneca.
Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q4 2025: Roche 17.1305, AstraZeneca 15.288.
* Roche reports semi-annually. Values are evenly split across both quarters within each half.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Roche, AstraZeneca.| Metric | Roche | AstraZeneca |
|---|---|---|
| Market Cap | - | - |
| Revenue | $34.26B | $15.29B |
| Cost of Revenue | $9.68B | $2.68B |
| Gross Profit | $24.58B | $12.61B |
| Operating Income | $7.96B | $4.25B |
| Net Income | $6.13B | $3.08B |
| R&D Expense | $7.48B | $3.49B |
| Earnings Per Share | $0.95 | $3.94 |
| Gross Margin | 71.7% | 82.5% |
| Operating Margin | 23.2% | 27.8% |
| Net Profit Margin | 17.9% | 20.1% |
| Free Cash Flow | $10.67B | $1.82B |
| Cumulative Free Cash Flow | $299.34B | $119.09B |
| Operating Cash Flow | $13.12B | $3.36B |
| Cash & Equivalents | $6.32B | $7.56B |